CVE Intelligence
Skip to main content
Memory Corruption

CVE-2026-86876

CVE-2026-86876 — An out-of-bounds write issue was addressed with improved bounds checking

An out-of-bounds write issue was addressed with improved bounds checking. This issue is fixed in iOS 26.7 and iPadOS 26.7, iOS 27 and iPadOS 27, macOS Golden Gate 27, macOS Sequoia 15.8, macOS Tahoe 26.7, visionOS 27, watchOS 27. A sandboxed process may be able to circumvent sandbox restrictions.

Published Updated Sources: NVD, Apple (CNA), GitHub, GitHub Security Advisory, SOCRadar CTI

Triage

Is it exploited, how likely is exploitation, what does it touch, and how severe do the scoring sources call it.

Exploitation

Unreported

no source claims exploitation

EPSS

0%

ahead of 0% of scored CVEs

Affects

Apple

7 products listed

CVSS base

Unscored

no source published a base score

Remediation

The vendor's own words where we have them.

Upgrade iOS and iPadOS to a fixed release. Apply vendor patches per advisory and restrict external exposure of the affected component until patched.

First 24 hours

Ordered from the record's own fields — exposure first, because you cannot patch what you have not found.

  • Identify exposed assets running affected vendor/product/version combinations.
  • Prioritize based on EPSS, PoC availability, and external exposure.
  • Search available logs for exploit probes, errors, authentication anomalies, or suspicious child processes matching the vulnerability class.

Affected scope

Vendor, product and version as the advisories word them.

VendorProductVersionsStatus
AppleiOS and iPadOS0 to < 26.7Vulnerable
AppleiOS and iPadOS0 to < 27Vulnerable
ApplemacOS0 to < 15.8Vulnerable
ApplemacOS0 to < 26.7Vulnerable
ApplemacOS0 to < 27Vulnerable
ApplevisionOS0 to < 27Vulnerable
ApplewatchOS0 to < 27Vulnerable

Weakness & attack patterns

Inferred from the weakness class — not observed against this CVE.

CAPEC-100 · Overflow BuffersCAPEC-123 · Buffer Manipulation

Timeline

What happened to this CVE, newest first — with the readings a source repeats on a schedule counted underneath rather than listed.

  1. 2026
  2. Initial · CVE published

    Sep 14, 2026 · NVD

  3. Added · GHSA-9rgh-hpwq-qxmv published (unknown)

    Sep 14, 2026 · GitHub Security Advisory

  4. CVE published by MITRE.

    Sep 14, 2026 · SOCRadar CTI

References

9 on the record

Coverage

1 story from the feeds we poll

Elsewhere on this site

Not in any source we poll

Listed rather than left blank: an empty field and an unmeasured one look identical on screen, and only one is a reason to look elsewhere.

  • No confirmed IOCs, IP addresses, domains, file hashes, or malware artifacts supplied.
  • No organization-specific asset inventory, compensating-control status, or patch deployment evidence supplied.
  • No exploit packet captures, log samples, or incident case IDs supplied.
Answered from this record1

What should defenders know first?

CVE-2026-86876 is An out-of-bounds write issue was addressed with improved bounds checking, a unscored vulnerability affecting iOS and iPadOS, macOS, visionOS, watchOS from Apple. The current evidence does not list it in CISA KEV, and the exploit status is: Active exploitation is not confirmed from current sources for CVE-2026-86876. Public exploit evidence is: A public PoC is not confirmed from current sources for CVE-2026-86876. The affected-version evidence is listed in the key facts and affected products tables. Defenders should first verify whether exposed or business-critical assets run those versions, then apply vendor patches or mitigations, restrict reachable attack surface, and preserve logs for detection review. CVSS null describes technical severity, while EPSS 0% helps estimate near-term exploit likelihood; neither replaces asset context. Unknown fields should remain explicit in tickets, and threat actor, IOC, victimology, or payload claims should not be added unless a cited source supports them. Monitor CISA KEV, vendor advisories, NVD changes, public PoC repositories, and internal telemetry for update triggers.